Literature DB >> 2170448

Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux.

E M Runnman1, S T Lamp, J N Weiss.   

Abstract

The effects of elevated glucose on cardiac function during hypoxia were investigated in isolated arterially perfused rabbit interventricular septa. Rest tension, developed tension, intracellular potential, 42K+ efflux, lactate production, exogenous glucose utilization, and tissue high-energy phosphate levels were measured during a 50-min period of hypoxia with 4, 5, or 50 mM glucose present (isosmotically balanced with sucrose) and during reoxygenation for 60 min with perfusate containing 5 mM glucose/45 mM sucrose. At physiologic (4 or 5 mM) and supraphysiologic glucose (50 mM), lactate production and high-energy phosphate levels during hypoxia were equally well maintained, yet cardiac dysfunction was markedly attenuated by 50 mM glucose. Despite identical rates of total glycolytic flux, exogenous glucose utilization was enhanced by 50 mM glucose so that tissue glycogen levels remained normal during hypoxia, whereas glycogen became depleted with 4 or 5 mM glucose present during hypoxia. Most of the beneficial effects of 50 mM glucose occurred during the first 25 min of hypoxia. Prior glycogen depletion had no deleterious effects during hypoxia with 50 mM glucose present, but exacerbated cardiac dysfunction during hypoxia with 5 mM glucose present. These findings indicate that enhanced utilization of exogenous glucose improved cardiac function during hypoxia without increasing total glycolytic flux or tissue high-energy phosphate levels, suggesting a novel cardioprotective mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170448      PMCID: PMC296852          DOI: 10.1172/JCI114828

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

1.  Estimation of glycogen in small amounts of tissue.

Authors:  E Van Handel
Journal:  Anal Biochem       Date:  1965-05       Impact factor: 3.365

2.  Outward current and repolarization in hypoxic rat myocardium.

Authors:  C H Conrad; R G Mark; O H Bing
Journal:  Am J Physiol       Date:  1983-03

3.  Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction.

Authors:  P L Whitlow; W J Rogers; L R Smith; H G McDaniel; S E Papapietro; J A Mantle; J R Logic; R O Russell; C E Rackley
Journal:  Am J Cardiol       Date:  1982-03       Impact factor: 2.778

Review 4.  Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction.

Authors:  C E Rackley; R O Russell; W J Rogers; J A Mantle; H G McDaniel; S E Papapietro
Journal:  Am Heart J       Date:  1981-12       Impact factor: 4.749

5.  The relationship between glycolysis, fatty acid metabolism and membrane integrity in neonatal myocytes.

Authors:  T J Higgins; D Allsopp; P J Bailey; E D D'Souza
Journal:  J Mol Cell Cardiol       Date:  1981-06       Impact factor: 5.000

6.  Glucose metabolism during ischemia due to excessive oxygen demand or altered coronary flow in the isolated arterially perfused rabbit septum.

Authors:  R C Marshall; W W Nash; K I Shine; M E Phelps; N Ricchiuti
Journal:  Circ Res       Date:  1981-09       Impact factor: 17.367

7.  Interrelationship between cellular metabolic status and susceptibility of heart cells to attack by phospholipase.

Authors:  T J Higgins; P J Bailey; D Allsopp
Journal:  J Mol Cell Cardiol       Date:  1982-11       Impact factor: 5.000

8.  Rate-tension staircase in rabbit ventricular muscle: relation to ionic exchange.

Authors:  J C Shelburne; S D Serena; G A Langer
Journal:  Am J Physiol       Date:  1967-11

9.  [K+]o accumulation and electrophysiological alterations during early myocardial ischemia.

Authors:  J Weiss; K I Shine
Journal:  Am J Physiol       Date:  1982-08

10.  Glucose, insulin, potassium protection during the course of hypothermic global ischemia and reperfusion: a new proposed mechanism by the scavenging of free radicals.

Authors:  M L Hess; E Okabe; J Poland; M Warner; J R Stewart; L J Greenfield
Journal:  J Cardiovasc Pharmacol       Date:  1983 Jan-Feb       Impact factor: 3.105

View more
  8 in total

1.  Exercise-induced myocardial ischemia: can this be imaged with F-18-fluorodeoxyglucose?

Authors:  D Jain; P H McNulty
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

2.  Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia.

Authors:  P H McNulty; A J Sinusas; C Q Shi; D Dione; L H Young; G C Cline; G I Shulman
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Hypoxia and glucose independently regulate the beta-adrenergic receptor-adenylate cyclase system in cardiac myocytes.

Authors:  K J Rocha-Singh; N Y Honbo; J S Karliner
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  ATP-sensitive K+ channels and cellular K+ loss in hypoxic and ischaemic mammalian ventricle.

Authors:  J N Weiss; N Venkatesh; S T Lamp
Journal:  J Physiol       Date:  1992-02       Impact factor: 5.182

5.  Oscillations at odds in the heart.

Authors:  James N Weiss; Jun-Hai Yang
Journal:  J Gen Physiol       Date:  2010-03-15       Impact factor: 4.086

6.  Increased expression of H11 kinase stimulates glycogen synthesis in the heart.

Authors:  Li Wang; Anna Zajac; Nadia Hedhli; Christophe Depre
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

7.  Depletion of myocardial glucose is observed during endotoxemic but not hemorrhagic shock in a porcine model.

Authors:  Michelle S Chew; Kiran Shekar; Björn A Brand; Carl Norin; Adrian G Barnett
Journal:  Crit Care       Date:  2013-07-25       Impact factor: 9.097

8.  High glucose regulates the activity of cardiac sarcolemmal ATP-sensitive K+ channels via 1,3-bisphosphoglycerate: a novel link between cardiac membrane excitability and glucose metabolism.

Authors:  Sofija Jovanović; Aleksandar Jovanović
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.